J&J’s Covid-19 vaccine may trigger neurological condition in rare cases, FDA says

Johnson & Johnson’s Covid-19 vaccine may trigger a rare neurological condition in a small number of people who receive the vaccine, the Food and Drug Administration said Monday.

Reports to a database operated jointly by the agency and the Centers for Disease Prevention and Control suggest there may be a link between the inoculations and Guillain-Barré syndrome, a form of progressive paralysis that is generally reversible, the FDA said in a statement.

Read the rest…

J&J’s Covid-19 vaccine may trigger neurological condition in rare cases, FDA says

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top